
UK-based Synairgen has signed a global licence agreement with fellow British native AstraZeneca for its experimental lung drug SNG001. The …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

